Revenue

Aiforia's revenue development in the last quarter has been impacted by a combination of factors, primarily related to the timing of revenue recognition. The company's expansion into new markets, such as the Paris region and a new regional healthcare provider in Spain, has contributed to a delay in revenue recognition, as these agreements only commenced in the second half of the year. Furthermore, delays in certain ongoing customer agreements have also slowed revenue development. Despite these challenges, Aiforia's customer satisfaction remains strong, and the company's customer retention continues to be excellent. The company's ability to adapt to changing market conditions and customer needs will be crucial in driving future revenue growth.

The realised revenue for Q2 2026 is 0.4 million Euros, while the predicted revenue for Q2 2027 (e) is 1.0 million Euros. The revenue is expected to increase by 0.6 million Euros, which is a 50% change from the realised value to the predicted value. The revenue is expected to decrease by 0.9 million Euros from 2025 to 2026, which is a 25.7% decrease. From 2026 to 2027, the revenue is expected to increase by 1.0 million Euros, which is a 38.5% increase. The annual revenue values are 3.5 million Euros in 2025, 2.6 million Euros in 2026, and 3.6 million Euros in 2027.

Ebit

Aiforia's EBIT profitability has experienced a significant decline, indicating a substantial increase in operating expenses. This deterioration is largely attributed to the company's investments in product development, which are expected to drive future growth. However, the timing of revenue recognition for certain agreements has also contributed to the decline, as these contracts only commenced in the second half of the year. Furthermore, delays in ongoing customer agreements have slowed down revenue development in the first half, exacerbating the EBIT profitability issue. Despite these challenges, Aiforia's management remains committed to accelerating the deployment of its products and expediting the conversion of its order book into revenue.

The realised Ebit for Q2 2026 is -3.8 million Euros, while the predicted Ebit for Q2 2027 (e) is -2.7 million Euros. The expected change in Ebit from Q2 2026 to Q2 2027 (e) is an increase of 0.1 million Euros, which translates to a percentage decrease of approximately 2.6%. The expected change in Ebit from 2025 to 2026 is a decrease of 1.3 million Euros, which is a 11.5% drop. From 2026 to 2027, the expected change is a decrease of 3.5 million Euros, which is a 28% drop. The annual Ebit values are -11.2 million Euros in 2025, -12.5 million Euros in 2026, and -9.0 million Euros in 2027.

Profit befor tax

The profit before tax in Q2 2026 is -3.8 million Euros, and in Q2 2027 (e) it is expected to be -2.7 million Euros. The expected change in one year is an increase of 0.1 million Euros, which translates to a 2.6% improvement. The change in Profit before tax from 2025 to 2026 is a decrease of 0.1 million Euros, which is a 0.8% decrease. The change from 2026 to 2027 is a decrease of 3.6 million Euros, which is a 30% decrease. The annual values for Profit before tax are -12.7 million Euros in 2025, -12.6 million Euros in 2026, and -9.0 million Euros in 2027.

Profit

The realised profit for Q2 2026 is -3.8 million Euros, while the predicted profit for Q2 2027 (e) is -2.2 million Euros. The expected change in profit from Q2 2026 to Q2 2027 (e) is 1.6 million Euros, which represents a decrease of 42.1% from the realised value. The expected change in profit from 2025 to 2026 is a decrease of 0.9 million Euros, which is a 7.1% decrease. From 2026 to 2027, the expected change is a decrease of 4.4 million Euros, which is a 38.5% decrease. The annual profit values are -12.7 million Euros in 2025, -11.6 million Euros in 2026, and -7.2 million Euros in 2027.